Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Mufei Biotechnology is a Chinese biotechnology company specializing in the research, development, and production of natural plant extracts and bioactive ingredients. Founded in 2020 and based in Xi'an, the company provides a wide range of products including Albizia Julibrissin bark extract, Yacon fruit extract, and Gynostemma extract for the cosmetics, nutraceutical, and food industries. Their business model focuses on the extraction, purification, and synthesis of marine and terrestrial biological substances. The company serves as a key supplier for global health and beauty brands, offering raw materials for anti-aging, sleep support, and general wellness applications. Shaanxi Mufei Biotechnology operates as a private entity and is recognized as a significant player in the regional botanical extract market in Shaanxi province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Mufei Biotechnology.